Therapeutic approaches in the chronic obstructive (COPD) pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 472s Year: 2002
OdyseiBG – systematic approach for complex assessment and staging of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 243s Year: 2003
Chronic obstructive pulmonary disease in heart failure: prevalence, therapeutic and prognostic implications Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD Year: 2009
The link between inflammation and lung cancer: lessons from chronic obstructive pulmonary disease Source: International Congress 2018 – Scientific Year in Review Year: 2018
Chronic obstructive pulmonary disease: the patient perspective Source: Eur Respir J 2001; 18: Suppl. 33, 401s Year: 2001
Improvement of diagnosis and treatment of obstructive lung diseases with a one stop diagnostic consultancy Source: Annual Congress 2006 - COPD – the challenges for primary care Year: 2006
Optimal assessment and management of chronic obstructive pulmonary disease (COPD) Source: Guideline 1995 Year: 1995
How we can modify the steroid insensitivity in patients with chronic obstructive pulmonary disease? The new pharmacological approach to old problem Source: Annual Congress 2011 - COPD management Year: 2011
Managing deteriorations in chronic obstructive pulmonary disease: which organ is failing? Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure Year: 2018
Future research in chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=470 Year: 2006
Emerging anti-inflammatory strategies for COPD}, Source: Eur Respir J 2012; 40: 724-741 Year: 2012
Differentiating asthma from chronic obstructive pulmonary disease (COPD) in medico-economic databases: myth or reality? Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019
Combination therapy for chronic obstructive pulmonary disease: one size fits all? Source: Eur Respir J 2003 Dec 01;22(6):874-875 Year: 2003
Searching for chronic obstructive pulmonary disease in the over 65 people: suggestions for a cost-effective approach Source: Eur Respir J 2004; 24: Suppl. 48, 360s Year: 2004
Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020
Are severe asthma and chronic obstructive pulmonary disease the same disease? Source: Annual Congress 2006 - Smoking asthmatics – a neglected population? Year: 2006
Defining airflow limitation and chronic obstructive pulmonary disease: the role of outcome studies Source: Eur Respir J 2015; 46: 8-10 Year: 2015
The molecular and clinical diseasomeof comorbid diseases inchronic obstructive pulmonary disease Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015
Possible mechanisms underlying the development of cachexia in COPD Source: Eur Respir J 2008; 31: 492-501 Year: 2008
Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009